Uniogen's progress toward clinical commercialization aligns with larger internal goals of bringing cancer diagnostics to market, with a specific focus on women's health.

Ovarian cancer, often a \"silent killer,\" is the 8th most common cancer in women globally and the third in India. Early ...

Blood tests that promise to spot cancer before symptoms appear are racing toward clinics, pitched as a simple vial of blood ...

Long wait times for gynecological surgeries are putting many Canadian women at risk, doctors say. Surgical wait times vary across the country, but a 2020 study found that a gynecologist consultation ...

CBD and THC kill ovarian cancer cells at doses that largely spare normal cells, disrupting survival pathways through multiple ...

In the future, scientists could use drugs made from cannabis to fight ovarian cancer. A team of scientists testing the ...

Hua-Ying Fan, PhD, hopes that her team's latest discovery could help the almost 21,000 people who are expected to receive an ...

RHY’s geneType twice as effective at identifying women with elevated ovarian cancer risk than using clinical or genetic information alone Peer-reviewed study validates Rhythm’s ovarian cancer risk ...

The FDA has approved three self-administered tests for the high-risk strains of HPV known to cause most cervical cancers.

Breast cancer comes with many variables. A pair of powerful genomic tests can help women and their care teams make ...

The Maria star, 50, candidly revealed why she's chosen to show the results of her preventive double mastectomyfrom over a ...

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...